A translational paradigm for inducing behavioral analogs of anhedonia in rodents and humans involves challenges that induce immune system activation and increase the gene expression of proinflammatory cytokines. This inflammation-induced change in behavior is consistent with the notion that these cytokines signal the brain to initiate 'sickness behavior,' a motivational response to infection or disease that is thought to promote recovery from illness. As such, anhedonia has been conceived of as an adaptive response to sickness that promotes recuperative behavior and prevents individuals from engaging in activities that require excessive energy. Since peripheral cytokines can cross the blood-brain-barrier (BBB), and also can propagate signals across the BBB that induce the production of cytokines from glia, measurement of peripheral markers of inflammation is a valid, if indirect assessment of CNS inflammation. The proposed study aims to test the hypothesis that within a mood disorder sample, the gene transcripts obtained from peripheral blood mononuclear cells (PBMCs), anhedonia ratings, and deficits in positive valence systems will be intercorrelated. In pilot studies of individuals presenting with various mood disorders we obtained preliminary evidence that gene expression within PBMCs is abnormal within a gene network implicated in inflammation and neurological disorders, and that the mRNA levels from these genes individually show positive correlations with anhedonia ratings in mood disordered and healthy individuals. Because the transcript levels of the implicated genes within this network are inter-correlated, we will use the covariance matrix formed by the mRNA levels in discriminant analysis type-functions to classify cases on the basis of having elevated or non-elevated gene network activity. We will assess the mRNA activity of this network along a dimension of anhedonic mood symptoms and of behavioral and neurophysiological measures that reflect multiple constructs within the positive valence systems. More specifically, we will assess interrelationships between gene transcription, anhedonia ratings, functional MRI (fMRI) measures of neurocircuits engaged during reward evaluation and initial responsiveness to reward attainment, and fMRI and behavioral responses reflecting effort evaluation/ wiIlingness to work in relation to changing reward values. The fMRI paradigms selected for this purpose involve behavioral tasks in which the emotional valence and reward value are manipulated orthogonally to changes in task difficulty. They thus afford excellent opportunities to evaluate separately the neural and behavioral responses associated with decrements in motivation versus reductions in experienced pleasure that are crucial to the development of translational models of anhedonia arising within the context of mood disorders.

Public Health Relevance

The goal of the proposed research is to assess gene transcription from white blood cells, imaging measures of brain function and behavioral assessments of reward responsiveness along a dimension of anhedonic mood symptoms. We will attempt to prove that inflammation plays a major role in the onset and perpetuation of the reduction in pleasure and motivation that many individuals experience in the clinical conditions that currently are subsumed under the diagnostic categories of depression, other mood disorders or chronic fatigue. We hope to identify an abnormal pattern of gene transcription and brain function that will be sufficiently distinct from the normal pattern that it can be used to objectively establish a diagnosis based on biology, as opposed to self-reported symptoms, and that this diagnostic category will predict the likelihood that an individual with this disorder wil benefit from particular types of treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH098099-04
Application #
8906942
Study Section
Special Emphasis Panel (ZMH1-ERB-S (04))
Program Officer
Meinecke, Douglas L
Project Start
2012-09-01
Project End
2016-07-31
Budget Start
2015-08-01
Budget End
2016-07-31
Support Year
4
Fiscal Year
2015
Total Cost
$550,301
Indirect Cost
$187,937
Name
Laureate Institute for Brain Research
Department
Type
DUNS #
967230579
City
Tulsa
State
OK
Country
United States
Zip Code
74136
Misaki, Masaya; Phillips, Raquel; Zotev, Vadim et al. (2018) Connectome-wide investigation of altered resting-state functional connectivity in war veterans with and without posttraumatic stress disorder. Neuroimage Clin 17:285-296
Misaki, Masaya; Phillips, Raquel; Zotev, Vadim et al. (2018) Real-time fMRI amygdala neurofeedback positive emotional training normalized resting-state functional connectivity in combat veterans with and without PTSD: a connectome-wide investigation. Neuroimage Clin 20:543-555
Le, Trang T; Simmons, W Kyle; Misaki, Masaya et al. (2017) Differential privacy-based evaporative cooling feature selection and classification with relief-F and random forests. Bioinformatics 33:2906-2913
Suzuki, Hideo; Savitz, Jonathan; Kent Teague, T et al. (2017) Altered populations of natural killer cells, cytotoxic T lymphocytes, and regulatory T cells in major depressive disorder: Association with sleep disturbance. Brain Behav Immun 66:193-200
Misaki, Masaya; Suzuki, Hideo; Savitz, Jonathan et al. (2016) Individual Variations in Nucleus Accumbens Responses Associated with Major Depressive Disorder Symptoms. Sci Rep 6:21227
Suzuki, Hideo; Lucas, Louis R (2015) Neurochemical correlates of accumbal dopamine D2 and amygdaloid 5-HT 1B receptor densities on observational learning of aggression. Cogn Affect Behav Neurosci 15:460-74
Misaki, Masaya; Savitz, Jonathan; Zotev, Vadim et al. (2015) Contrast enhancement by combining T1- and T2-weighted structural brain MR Images. Magn Reson Med 74:1609-20